News articles about Healthequity (NASDAQ:HQY) have trended somewhat positive on Sunday, according to Accern. The research group ranks the sentiment of news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Healthequity earned a media sentiment score of 0.24 on Accern’s scale. Accern also gave news coverage about the company an impact score of 46.1185596512092 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Several research firms recently weighed in on HQY. Zacks Investment Research upgraded Healthequity from a “hold” rating to a “buy” rating and set a $60.00 price target on the stock in a research report on Wednesday, November 8th. BidaskClub upgraded Healthequity from a “sell” rating to a “hold” rating in a research report on Tuesday, November 7th. Chardan Capital lifted their price target on Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a research report on Wednesday, December 6th. Cantor Fitzgerald restated a “buy” rating and set a $56.00 price target on shares of Healthequity in a research report on Monday, September 25th. Finally, Citigroup started coverage on Healthequity in a research note on Thursday, January 4th. They set a “buy” rating for the company. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Healthequity currently has an average rating of “Buy” and an average target price of $58.33.
Healthequity (HQY) opened at $48.21 on Friday. The stock has a market capitalization of $2,936.55, a price-to-earnings ratio of 65.15, a price-to-earnings-growth ratio of 2.00 and a beta of 1.74. Healthequity has a one year low of $37.62 and a one year high of $55.31.
In other news, VP Darcy G. Mott sold 9,500 shares of the business’s stock in a transaction on Wednesday, December 20th. The stock was sold at an average price of $47.91, for a total value of $455,145.00. Following the completion of the transaction, the vice president now owns 96,500 shares in the company, valued at $4,623,315. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Frank Medici sold 419,504 shares of the business’s stock in a transaction on Monday, November 6th. The stock was sold at an average price of $52.97, for a total value of $22,221,126.88. Following the completion of the transaction, the director now owns 6,381 shares of the company’s stock, valued at approximately $338,001.57. The disclosure for this sale can be found here. Insiders have sold 1,106,934 shares of company stock valued at $57,943,828 in the last quarter. 29.00% of the stock is owned by company insiders.
TRADEMARK VIOLATION WARNING: This story was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this story on another domain, it was illegally copied and republished in violation of United States and international copyright & trademark law. The legal version of this story can be accessed at https://sportsperspectives.com/2018/01/21/healthequity-hqy-earning-somewhat-favorable-news-coverage-report-shows.html.
Healthequity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.